9 Meters Biopharma Inc. (NASDAQ:NMTR) price closed lower on Monday, September 13, dropping -2.29% below its previous close.
A look at the daily price movement shows that the last close reads $1.31, with intraday deals fluctuated between $1.185 and $1.3199. The company’s 5Y monthly beta was ticking -0.22. Taking into account the 52-week price action we note that the stock hit a 52-week high of $2.26 and 52-week low of $0.63. The stock added 20.75% on its value in the past month.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give NMTR a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as Hold.
The overview shows that NMTR’s price is at present 5.44% off the SMA20 and 11.63% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 59.66, with weekly volatility standing at 5.87%. The indicator jumps to 5.24% when calculated based on the past 30 days. 9 Meters Biopharma Inc. (NASDAQ:NMTR)’s beta value is holding at -4.02, while the average true range (ATR) indicator is currently reading 0.06.
An analysis of the 9 Meters Biopharma Inc. (NASDAQ:NMTR) stock in terms of its daily trading volume indicates that the 3-month average is 4.33 million.
Current records show that the company has 249.55M in outstanding shares. The insiders’ percentage holdings are 1.00% of outstanding shares while the percentage share held by institutions stands at 30.20%. But the 49.01% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.